Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Intriguing Results for Nanopore Sequencing from Defunct Roche-IBM Partnership

    Dec 9, 2014, 09:20 AM by Michael Croft
    Bio-IT World | Researchers from Arizona State University and IBM’s TJ Watson Research Center present the development of a solid state tunneling device sensitive to nucleotides. The next steps may reveal the direction in which nanopore sequencing is heading.
    Full story
  • Hearing Aids Market Worth USD 5,440.5 Million By 2020: Grand View Research, Inc

    Dec 9, 2014, 00:00 AM by Michael Croft
    SAN FRANCISCO, CA - Dec 9, 2014 - The global market for hearing aids is expected to reach USD 5,440.5 million by 2020, growing at an estimated CAGR of 3
    Full story
  • Global Aluminum Chloride Market Size, Share, Growth, Trends and Forecast to 2014

    Dec 9, 2014, 00:00 AM by Michael Croft
    SAN FRANCISCO, CA - Dec 9, 2014 - was a professional and depth research report on Global Aluminum Chloride industry that you would know the world's major regional market conditions of Aluminum Chloride industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc
    Full story
  • Global Automated Test Equipment Market Trends, Growth and Forecast up to 2020: Hexa Research

    Dec 9, 2014, 00:00 AM by Michael Croft
    CALIFORNIA, UNITED KINGDOM - Dec 9, 2014 - Industry InsightsThe ATE market has potential for high growth due to demand from consumer electronics industry
    Full story
  • Medical Robotic Systems Market Growth & Forecast in India up to 2020: Hexa Research

    Dec 9, 2014, 00:00 AM by Michael Croft
    CALIFORNIA, CA, UNITED STATES - Dec 9, 2014 - Industry InsightsRising penetration of automated or computerized surgical technologies such as nanorobots or telemedicine or bacteriobots for treating fatal diseases such as cancer is expected to boost market growth in coming six years
    Full story
  • Global Skincare Devices Market Worth USD 12,799.5 Million By 2020: Grand View Research, Inc.

    Dec 9, 2014, 00:00 AM by Michael Croft
    SAN FRANCISCO, CA - Dec 9, 2014 - The global market for skincare devices is expected to reach USD 12,799.5 million by 2020, growing at an estimated CAGR of 10
    Full story
  • Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Report To 2020: Grand View Research, Inc.

    Dec 9, 2014, 00:00 AM by Michael Croft
    SAN FRANCISCO, CA - Dec 9, 2014 - Global ITP therapeutics market is expected to reach USD 566.37 million by 2020, according to a new study by Grand View Research, Inc
    Full story
  • Asia Pacific Genomics Market Expected To Grow At CAGR Of 12.7% From 2014 To 2020: Grand View Research, Inc.

    Dec 9, 2014, 00:00 AM by Michael Croft
    SAN FRANCISCO, CA - Dec 9, 2014 - The global market for genomics is expected to reach USD 22.1 billion by 2020, growing at an estimated CAGR of 10
    Full story
  • BaseHealth, Labco Sign European Partnership

    Dec 8, 2014, 10:00 AM by Michael Croft
    Bio-IT World | BaseHealth of Redwood City, Calif., has announced a partnership with the European diagnostics network Labco to deploy BaseHealth’s Genophen platform to thousands of physicians across Europe
    Full story
  • Terascala Rolls Out Lustre 2.5.3 to Production

    Dec 8, 2014, 00:00 AM by Michael Croft
    BOSTON, MA - Dec 8, 2014 -  Terascala, the industry leader in High Performance Computing (HPC) storage management software, today announced that it has released open-source parallel file system Lustre version 2
    Full story
  • Study finds support for newborn genetic testing among parents

    Dec 8, 2014, 00:00 AM by Michael Croft
    Boston Herald | Most parents would like to have their newborns genetically tested for medical conditions and disorders, according to a new study published this wee
    Full story
  • Druggability: An Underappreciated Issue in Translating the Human Genome Into Therapeutics

    Dec 8, 2014, 00:00 AM by Michael Croft
    Omics! Omics! Blog | Keith Robison: "It's sobering to think how few of the targets of current therapeutics could be found from genomics data."
    Full story
  • Controversy Over CRISPR Patents

    Dec 5, 2014, 09:55 AM by Michael Croft
    MIT Technology Review | As Editas Medicine claims exclusive licenses to use key intellectual property around the CRISPR-Cas9 gene editing system, many of the innovators of this technology are disputing patent priority, or even the right to patent foundational CRISPR engineering techniques.
    Full story
  • RainDance Forms Hematologic Oncology Consortium to Develop Assays for Liquid Biopsy Research of Myeloid Disorders

    Dec 5, 2014, 00:00 AM by Michael Croft
    BILLERICA, MA - Dec 5, 2014 - RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetic diseases, today announced the formation of the RainDance HemOnc Consortium, composed of a select group of hematologic clinical research experts drawn from prominent comprehensive cancer centers in the U
    Full story
  • MIT and Massachusetts General Hospital Team Up on New Microbiome-Based Therapies

    Dec 4, 2014, 11:00 AM by Michael Croft
    Bio-IT World | Eric Alm, co-director of the new Center for Microbiome Informatics and Therapeutics at MIT and MGH, talks microbial therapies, new regulatory models, and the public appeal of our microbes.
    Full story
  • Thomson Reuters and Linguamatics Release New Solution to Advance Pharma Clinical Trial R&D(2)

    Dec 4, 2014, 00:00 AM by Michael Croft
    PHILADELPHIA, PA, UNITED STATES - Dec 4, 2014 - The Intellectual Property &  Science business of Thomson Reuters, the world leader in intelligent information for businesses and professionals, today announced a collaboration with Linguamatics to advance pharmaceutical clinical trial research and development (R&D) with the launch of  CortellisTM  Informatics Clinical Text Analytics for I2E
    Full story
  • Thomson Reuters and Linguamatics Release New Solution to Advance Pharma Clinical Trial R&D

    Dec 4, 2014, 00:00 AM by Michael Croft
    PHILADELPHIA, PA - Dec 4, 2014 - The Intellectual Property &  Science business of Thomson Reuters, the world leader in intelligent information for businesses and professionals, today announced a collaboration with Linguamatics to advance pharmaceutical clinical trial research and development (R&D) with the launch of  CortellisTM  Informatics Clinical Text Analytics for I2E
    Full story
  • Tute Genomics raises $2.3 million to scale up cloud-based genome analytics and accelerate personalized medicine

    Dec 4, 2014, 00:00 AM by Michael Croft
    PROVO, UT - Dec 4, 2014 - Tute Genomics, a leader in cloud-based solutions for genome analysis, has raised $2
    Full story
  • Pharma Multi-Millionaire Gives 100 Million To University of North Carolina

    Dec 4, 2014, 00:00 AM by Michael Croft
    Forbes | Former pharmaceutical executive Fred Eshelman has pledged $100 million to spur innovation at the UNC's pharmacy school.
    Full story
  • IP Deals Shed Light on Editas Medicine’s Strategy for CRISPR Gene Therapies

    Dec 2, 2014, 12:00 PM by Michael Croft
    Bio-IT World | Editas Medicine, a Cambridge company tackling therapies based on CRISPR gene editing, announced three intellectual property licensing deals with major research institutions this week, gaining exclusive access to key CRISPR-related technologies.
    Full story
  • «
  • 381
  • 382
  • 383
  • 384
  • 385 (current)
  • 386
  • 387
  • 388
  • 389
  • 390
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy